Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy in Patients With K-L Grade III Knee Osteoarthritis After JOINTSTEM Administration
Latest Information Update: 30 Sep 2022
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors R-Biopharm
- 27 Sep 2022 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 27 Sep 2022 Planned primary completion date changed from 1 Feb 2022 to 1 Aug 2024.
- 27 Sep 2022 Planned initiation date changed from 1 Jul 2021 to 1 Jul 2023.